Amit Verma Discusses Stock Market Correction, Trump Tariffs, And Their Impact On Pharma Sector

NDTV Profit

Published On

11 Mar 2025, 06:27 PM IST

Last Updated On

11 Mar 2025, 11:07 PM IST

In this episode of "Talking Point," we interviewed Amit Varma, Managing Partner at Quadria Capital. We discussed market volatility, the impact of Trump tariffs, and the future of the pharma and diagnostic sectors.

Add us to your Preferences

Set as your preferred source on Google

RECOMMENDED FOR YOU

US Tariffs: Only Sun Pharma Exposed To Some Headline Risk, But With Limited Earnings Impact

timelogo

Laurus Labs Downplays Impact Of New US Pharma Tariffs On Branded Drugs

timelogo

Trump Tariffs May Not Hurt Indian Companies, Says Morgan Stanley: THIS Pharma Stock An Exception

timelogo

Pharma Players To Counter US Tariff Pain? THIS D-Street Expert Has A Plan: 'Diversify Away From...'

timelogo